Anti-corruption probe launched into Oushadhi irregularities

Vigilance officials have begun a formal inquiry into reported irregularities at Oushadhi, the state-run pharmaceutical manufacturing unit. The investigation focuses on administrative and operational practices within the organization, sources familiar with the development said. The probe is being conducted to examine compliance with established procedures and to ascertain whether standard protocols were followed in various transactions and decisions. Authorities have indicated that the inquiry will be thorough and transparent, with findings to be documented for appropriate action. The investigation represents part of broader efforts by vigilance departments across the region to maintain accountability and efficiency in state-owned enterprises. Officials said all relevant records and documentation have been sought as part of the fact-finding process. The outcome of the inquiry is expected to provide clarity on the nature and scope of any alleged irregularities at the pharmaceutical unit.